All stock lists
GLAUKOS Corp (New York Stock Exchange:GKOS)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
178.27-0.61 (-0.34%)
Insider Score
––Not scored
GKOS Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
GKOS Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 185.61 M | 150.57 M | 143.12 M | 133.54 M | 124.12 M | 106.66 M |
| Revenue Growth (YoY) | 49.54 % | 41.16 % | 35.66 % | 38.14 % | 29.71 % | 24.58 % |
| Cost of Revenue | 34.02 M | 33.34 M | 31.77 M | 28.83 M | 26.90 M | 24.32 M |
| Gross Profit | 151.59 M | 117.23 M | 111.35 M | 104.71 M | 97.22 M | 82.35 M |
| SG&A Expense | 116.06 M | 92.94 M | 94.70 M | 83.00 M | 83.38 M | 70.67 M |
| R&D Expense | 51.30 M | 44.15 M | 43.65 M | 38.07 M | 36.54 M | 32.35 M |
| Operating Expenses | 168.86 M | 137.09 M | 138.35 M | 121.07 M | 119.91 M | 103.03 M |
| Operating Income | -17.27 M | -19.86 M | -27.00 M | -16.36 M | -22.69 M | -20.68 M |
| Pretax Income | -17.72 M | -19.30 M | -139.82 M | -16.00 M | -19.41 M | -17.82 M |
| Tax Provision | 656.00 K | 484.00 K | -6.16 M | 234.00 K | 248.00 K | 326.00 K |
| Net Income | -18.38 M | -19.78 M | -133.66 M | -16.23 M | -19.66 M | -18.15 M |
| EPS (Basic) | -0.31 | -0.34 | -2.32 | -0.28 | -0.34 | -0.32 |
| EPS (Diluted) | -0.31 | -0.34 | -2.32 | -0.28 | -0.34 | -0.32 |
| Shares Outstanding | 58.42 M | 58.02 M | 57.51 M | 57.40 M | 57.20 M | 56.64 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.